SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients ...Middle East

CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devices GALWAY, Ireland and WASHINGTON, March 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare...

Read More Details
Finally We wish PressBee provided you with enough information of ( SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients )

Also on site :

• This Common Over-the-Counter Medication May Harm Brain Health, Doctors Say—Do You Take It?
• In Q1 2025, enterprise SaaS M&A deal count hit 210, according to PitchBook
• Downtown Lincolnton on lockdown after 'credible threat,' police say no active shooter